Two Sigma Investments
GILD icon

Two Sigma Investments’s Gilead Sciences GILD Stock Holding History

Two Sigma Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530K Sell
3,800
-1,300
-25% -$182K ﹤0.01% 3705
2025
Q4 		$626K Buy
+5,100
New +$620K ﹤0.01% 3194
2022
Q1 		– Sell
-89,000
Closed -$6.46M – 3295
2021
Q4 		$6.46M Sell
89,000
-78,200
-47% -$5.39M 0.01% 1044
2021
Q3 		$11.7M Sell
167,200
-11,000
-6% -$773K 0.03% 698
2021
Q2 		$12.3M Sell
178,200
-281,000
-61% -$18.8M 0.03% 693
2021
Q1 		$29.7M Buy
459,200
+367,600
+401% +$23.7M 0.08% 296
2020
Q4 		$5.34M Sell
91,600
-222,800
-71% -$13.4M 0.02% 895
2020
Q3 		$19.9M Buy
314,400
+232,400
+283% +$16.1M 0.07% 299
2020
Q2 		$6.31M Buy
82,000
+33,600
+69% +$2.58M 0.03% 555
2020
Q1 		$3.62M Buy
48,400
+11,900
+33% +$822K 0.03% 655
2019
Q4 		$2.37M Sell
36,500
-184,900
-84% -$12M 0.01% 1451
2019
Q3 		$14M Buy
221,400
+92,700
+72% +$6.06M 0.05% 447
2019
Q2 		$8.7M Sell
128,700
-130,400
-50% -$8.58M 0.03% 652
2019
Q1 		$16.8M Buy
259,100
+183,100
+241% +$12.2M 0.05% 454
2018
Q4 		$4.75M Buy
76,000
+56,000
+280% +$3.91M 0.02% 826
2018
Q3 		$1.54M Sell
20,000
-281,200
-93% -$21.2M ﹤0.01% 1661
2018
Q2 		$21.3M Buy
301,200
+221,600
+278% +$15.6M 0.06% 390
2018
Q1 		$6M Buy
79,600
+62,600
+368% +$4.98M 0.02% 851
2017
Q4 		$1.22M Sell
17,000
-38,000
-69% -$2.89M ﹤0.01% 1821
2017
Q3 		$4.46M Sell
55,000
-3,700
-6% -$283K 0.02% 865
2017
Q2 		$4.16M Buy
58,700
+41,400
+239% +$2.75M 0.02% 958
2017
Q1 		$1.18M Sell
17,300
-9,500
-35% -$668K ﹤0.01% 1816
2016
Q4 		$1.92M Sell
26,800
-27,000
-50% -$2.01M 0.01% 1519
2016
Q3 		$4.26M Buy
53,800
+30,800
+134% +$2.5M 0.02% 973
2016
Q2 		$1.92M Sell
23,000
-32,000
-58% -$2.84M 0.01% 1286
2016
Q1 		$5.05M Buy
55,000
+6,000
+12% +$541K 0.02% 706
2015
Q4 		$4.96M Buy
49,000
+41,000
+513% +$4.27M 0.02% 666
2015
Q3 		$786K Buy
8,000
+2,000
+33% +$222K ﹤0.01% 1325
2015
Q2 		$702K Sell
6,000
-4,000
-40% -$437K ﹤0.01% 1897
2015
Q1 		$981K Buy
+10,000
New +$1.02M ﹤0.01% 1596

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Two Sigma Investments's GILD Position: Q1 2026 in Review

Two Sigma Investments opened a new position in Gilead Sciences (GILD) in Q1 2026: 13,500 shares worth $1.88M. The stake represents ﹤0.01% of the portfolio and ranks #2796 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in GILD as recently as Q1 2025.

Two Sigma Investments first reported a position in GILD in Q2 2013 and has held it in 45 quarters since. The position peaked at $254M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Two Sigma Investments held 13,500 shares of Gilead Sciences worth $1.88M as of Q1 2026.
  • Gilead Sciences was a new Two Sigma Investments position in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2796 holding.
  • Two Sigma Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 45 quarters since.
  • Two Sigma Investments's Gilead Sciences position peaked at $254M in Q4 2022.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.